Bain-Backed Tanabe Pharma Sets Goal of Three Drug Launches a Year in Japan
Bain-backed Mitsubishi Tanabe Pharma is targeting three new drug launches a year in Japan as its private equity owner pushes…
Bain-backed Mitsubishi Tanabe Pharma is targeting three new drug launches a year in Japan as its private equity owner pushes…
Asia's biggest banks posted further profit gains as higher rates widened lending margins, but cooling loan demand and rising funding…
Bain Capital has closed a $10.5 billion Asia fund, its largest yet, redirecting capital toward Japan and India as appetite…
Private equity capital in Asia is concentrating in India and Japan, two markets offering scale, stability, and clearer exit routes…
Hong Kong listings raised about HK$110 billion in Q1 2026, KPMG says, the city's strongest IPO quarter since 2021 and…
Ant International is preparing to raise about $1 billion as investor appetite for Asian fintech revives after a multi-year funding…
Southeast Asian startups raised $2.81B in Q1 2026, the lowest deal count in eight years, yet agentic AI startups kept…
Asia House expects Asia to anchor global growth in 2026, led by India and Vietnam above 6%, even as exports…
Warburg Pincus has agreed to buy J.S.B for about $1.2 billion, joining a crowded race to take undervalued Japanese listed…
AMRO keeps ASEAN+3 growth at 4.0% for 2026 but lifts its inflation forecast to 1.8% as a prolonged Middle East…